Veradermics, Inc
MANE$3.92B
Mid CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW HAVEN
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
5
Next Catalyst
Jun 29, 2026
9dMarket Overview
Stock performance and key metrics
MANE News
Catalyst Timeline
5 upcoming, 0 past
EarningsNext
MANE Earnings Report
Jun 29, 2026Confirmed
EPS Est: $-0.56 | FQ end 2026-03
4 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Drug Pipeline
VDPHL01
Androgenetic Alopecia
VDPHL01 QD
Androgenetic Alopecia (AGA)
VDMN-21 Patch Low Dose
Verruca Vulgaris
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VDPHL01 | Phase 3 | Androgenetic Alopecia | - | - |
VDPHL01 QD | Phase 3 | Androgenetic Alopecia (AGA) | - | - |
VDMN-21 Patch Low Dose | Phase 2 | Verruca Vulgaris | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply